Objective: The purpose of this study was to explore the level of coronavirus disease 2019 (COVID-19) vaccine hesitancy among medical students in Wuhan, China, and to identify the factors and barriers associated with their vaccination decision. Methods: A cross-sectional survey was launched with 612 medical students recruited by convenience sampling from 6 universities. Data collection measures mainly included a demographic questionnaire, COVID-19 vaccine knowledge questionnaire, and the vaccine hesitancy scale. Results: A total of 58.2% of medical students reported vaccine hesitancy. The most common reasons for this were worrying about the side effects of vaccines (44.4%), uncertainty about vaccine safety (40.4%), and underestimating the risk of exposure to COVID-19 (27.9%). The main factors associated with COVID-19 vaccine hesitancy among participants were their knowledge about COVID-19 vaccine, training related to COVID-19 vaccines, family address, and education level (P < 0.05). Conclusions: The government, health department and universities in China need to work together and actively communicate with vaccine-hesitant students, establish a standardized COVID-19 vaccine course, and provide on-campus vaccination services.
Background: The uric acid to high-density lipoprotein cholesterol ratio (UHR) is emerging as a novel biomarker reflecting the balance between pro-oxidative and antioxidative pathways. While implicated in various cardiometabolic diseases, its specific correlation with stroke risk, particularly across diverse populations, remains insufficiently characterized. This study aimed to investigate the UHR-stroke link in two independent populations. Methods: This cross-sectional analysis utilized data from 27,439 NHANES participants (2007–2018). We employed survey-weighted multivariable logistic regression to model the UHR-stroke correlation, complemented by restricted cubic splines (RCS) for dose-response relationships and subgroup analyses to assess effect modification. Furthermore, an external validation dataset comprising 1780 patients from The Central Hospital of Shaoyang was recruited to independently validate the primary findings. Results: A significant positive correlation was consistently observed between elevated UHR levels and increased stroke risk in both populations. Each unit increase in UHR corresponded to an adjusted OR of 1.03 (95% CI: 1.01–1.05) in NHANES and 1.06 (95% CI: 1.02–1.10) in the Chinese dataset. Similarly, an increasing trend in risk was evident across higher UHR quartiles. Dose-response trends were evident in both datasets ( P for trend < 0.05), with restricted cubic spline supporting a linear correlation. Subgroup analyses were robust across multiple sensitivity and multivariable-adjusted models. Conclusion: UHR is consistently and positively associated with stroke risk in both U.S. and Chinese populations. These findings, derived from multi-ethnic and external validation dataset, strengthen the evidence for UHR as a practical biomarker for stroke risk assessment, potentially reflecting underlying oxidative-antioxidant imbalance.
Background Post-percutaneous coronary intervention (PCI) patients frequently experience multidimensional symptoms (somatic, psychological, social), yet research remains fragmented. Current evidence lacks integration of dynamic symptom interactions and longitudinal evolution patterns. This study addresses critical gaps by characterising latent symptom classes and transition mechanisms during recovery, accounting for sociodemographic environmental influences across three Chinese provinces. Methods and analysis A multicentre study combines cross-sectional baseline assessment (T0) with prospective longitudinal follow-ups at 1 month (T1) and 6 months (T2) post-PCI. We will recruit 600 patients presenting with acute coronary syndrome and undergoing their first PCI from six Class A Tertiary Hospitals across Hunan, Jiangsu and Hainan provinces (July 2025–January 2026). Symptom phenotyping will use validated instruments: Patient-Reported Outcomes Measurement Information System-29, Tampa Scale for Kinesiophobia and Gastrointestinal Symptom Rating Scale. Latent profile analysis will identify baseline symptom profiles; latent transition analysis will model probabilities of transitioning between classes over time. Model selection will optimise fit indices (Akaike information criterion/Bayesian information criterion/bootstrap likelihood ratio test bootstrap) and clinical interpretability. Covariate-adjusted analyses will explore sociodemographic and environmental effects on symptom trajectories. Ethics and dissemination Approved by the University of South China Ethics Committee (2024NHHL037). Written informed consent precedes participation, with data deidentified and securely stored. Findings will be published in peer-reviewed journals following Strengthening the Reporting of Observational Studies in Epidemiology guidelines and presented at international cardiovascular conferences. Trial registration number ChiCTR2500097028.